Citazione APA

Zhang, Y., Chen, H., Liu, Y., Peng, F., Yu, M., Wang, W., . . . Lu, Y. (2019). Significant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in lung squamous cell cancer: A case report. World J Clin Cases.

Stile di citazione Chicago

Zhang, Yan, Hui-Min Chen, Yong-Mei Liu, Feng Peng, Min Yu, Wei-Ya Wang, Heng Xu, Yong-Sheng Wang, e You Lu. "Significant Benefits of Osimertinib in Treating Acquired Resistance to First-generation EGFR-TKIs in Lung Squamous Cell Cancer: A Case Report." World J Clin Cases 2019.

Citazione MLA

Zhang, Yan, et al. "Significant Benefits of Osimertinib in Treating Acquired Resistance to First-generation EGFR-TKIs in Lung Squamous Cell Cancer: A Case Report." World J Clin Cases 2019.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.